All lobbying filings
Van Scoyoc Associates
Van Scoyoc Associates filed a Q4 report for Quva Pharma, Inc. on January 19, 2026, reporting $50,000 in lobbying income.
Lobbying for Quva Pharma, Inc. · 503B outsourcing facility
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Texas
Government bodies contacted
2
Lobbying activity
1
Outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act